Epic dominates, Oracle Health evaporates. The 2026 KLAS report on acute care hospital EHR market share as of end of 2025 is not a cheerful earful for Oracle Health.  From a reader comment published on HIStalk 5/27/26, Epic’s market share now tops 56.9% of hospital beds. Trailing far behind is Oracle with 20.4% and niche player MEDITECH with 12.5%. What’s more disturbing are the trends.

From KLAS’ brief unpaywalled summary:

• The number of hospitals impacted by EHR purchase decisions dropped 40% compared to 2024 and nearly 50% compared to 2023.
• Acute care EHR purchase energy declined significantly in 2025, driven by several converging factors. Ongoing questions around government policy contributed to hesitation, and at the same time, many health systems redirected investment toward technologies with more immediate financial returns, such as AI and other solutions designed to improve operational efficiency.
• Additionally, while Oracle Health has continued to lose market share, many Oracle Health customers have been deferring action as they await greater clarity on the vendor’s evolving direction.

In this stagnant picture, the commenter ‘Spinout’, who clearly has report access, adds that:

• Epic continued to take customers away from Oracle Health, adding 77 hospitals with 19,000 beds in 2025 while Oracle Health lost 56 hospitals with 15,000 beds. (This is absolute confirmation of what this Editor has heard from industry people–that Oracle is now an also-ran EHR.)
• Oracle Health customer satisfaction continues to go down. One-third of its customers say Oracle isn’t in their long-term plans while another one-third say they might want to leave or would if they could. That leaves the company’s AI-powered EHR as a make-or-break product. (With a shortage of AI data center capacity, TTA 14 May, welcome to downtime)
• Third-place vendor Meditech continues to increase customer retention as its legacy clients increasingly choose Expanse instead of a new vendor.

What this may mean. It’s becoming all too easy, too logical, to make the case that Oracle Health has turned into a losing proposition, one that Larry Ellison can no longer afford even if he owns 40% of the company. One senses a pile of dirt, a hole, and a shovel. Mr. Ellison also needs money, which makes it even more likely that Oracle Health is spun off or sold for cash. 

From this Editor’s earlier article about the 30,000+ Oracle layoffs (10,000 in the US, with 539 employees laid off effective 26 May-1 June in Kansas City, Cerner’s former HQ and presumably where most EHR staff remained): Is Health, once the focus of Oracle’s Big Transformation, now just a used and broken toy? What’s the future of Oracle Health if the strategy is AI 24/7 and EHRs and healthcare system SaaS just do not fit the picture anymore?

Yet Oracle cannot simply close the division and turn off the systems. In addition to hospitals and health systems, let’s not forget that the VA is back to sprinting towards an implementation schedule ending in 2031. The EHR Modernization has 13 VA locations to cutover this calendar year, with 26 new sites in 2027 and 28 in 2028. Oracle will literally jeopardize every Federal contract they have if they botch VA EHRM. In short–Oracle Health is one of several bottomless pits Oracle faces.

Walgreens’ leases on the market–see A&G Real Estate Partners. One of the outcomes of Walgreens’ reorganization is a drastic downsizing of its retail footprint. Both city and suburban/rural locations have been affected, to the distress of many communities. Of note is the organization that the New Walgreens has chosen in this process is A&G Real Estate Partners, which specializes in companies exiting their retail locations due to Chapter 11 bankruptcies, such as Saks Global, Party City, over 1,000 Rite Aid leases, and Bed Bath and Beyond. A&G is marketing a mix of 78 Walgreens store leases and owned properties nationwide, per their presence at the ICSC retail real estate confab in Las Vegas. Sycamore Partners, the new owner, has deep experience in retail, so that their choice of real estate marketer is not surprising. One can expect that number to increase as the three-year plan has 1,200 closures and Walgreens, in layoffs announced earlier this year, reiterated that they were closing dozens of locations this year [TTA 27 Feb]. FTA, “A&G expects the same kinds of retailers that were interested in the Rite Aid stores to be interested in Walgreens, as well as possibly specialty grocery chains and healthcare providers, according to (principal) Joe McKeska.” A&G principals at ICSC met with these retailers as well as lenders and investors. CoStar

On to cheerier news

Oura has confidentially filed an S-1 with the Securities and Exchange Commission (SEC) for an IPO. The Finland-based smart ring developer did not state pricing nor number of shares in the preliminary filing.

Pre-IPO, Oura is on a roll as well, with up to 5.5 million devices sold, $1 billion in revenue, and 1,200 health partners. Their investments have been substantial. Oura’s most recent jumbo Series E of $900 million in October 2025 topped a Series D of $250 million in 2024, sandwiching a debt financing of $250 million in September 2025. Major investors are Fidelity and Dexcom, the latter announcing a partnership and $75 million investment in November 2024. Oura has also been on an acquisition tear: Doublepoint in March, Sparta Science and Veri in 2024, and Proxy in 2023.  Last October, FDA authorized a trial with Oura users of a new blood pressure feature. It also has partnerships in women’s health and hormone tracking. Most recently, last week Oura announced a partnership with Resmed, giving users access to a sleep assessment and educational resources.  Oura release, Healthcare Dive, Mobihealthnews

Swoop just scooped up NimbleRx. Acquisition cost was not disclosed. Swoop is a data platform for life sciences companies that enables marketing to both patients and healthcare providers, engaging them via targeting, community engagement, AI-powered web solutions, coordinated omnichannel activation, and now prescription fulfillment. NimbleRx streamlines workflows for pharmacy providers and prescription management for both pharmacies and patients, and claims coverage of 16 million patients. Their service will now be known as SwoopRx by Nimble. This is Swoop’s second acquisition in the past year, with MyHealthTeam, an opt-in patient social network for 62 conditions. Release, Mobihealthnews